Abstract
Hepatic transporters play a vital role in the disposition of endogenous compounds and xenobiotics in the liver. The current study investigates the expression and regulation of hepatic efflux transporters in response to treatment with the peroxisome proliferator-activated receptor (PPAR)α agonist clofibrate (CFB). Changes in mRNA and protein levels for several hepatic transporters were assessed in male CD-1 mice after 10 days of CFB dosing (500 mg/kg i.p.). Administration of CFB up-regulated mRNA levels for breast cancer resistance protein (Bcrp) and multidrug resistance-associated proteins 3 and 4 (Mrp3 and Mrp4, respectively). Western blot analysis confirmed that CFB enhances protein expression of liver Bcrp, Mrp3, and Mrp4 in CD-1 mice. To further characterize the regulation of these hepatic transporters, CFB-mediated changes in transporter mRNA levels were assessed in wild-type (sv/129) and PPARα-null male mice. Wild-type mice treated with CFB showed similar changes in mRNA levels for all of these transporters, whereas the PPARα-null mice did not. Although protein expression of Mrp3 and Mrp4 in the wild-type mice correlated well with changes in mRNA levels, Bcrp protein was not up-regulated by CFB treatment. These results show that PPARα activation by CFB coordinately regulates the hepatic efflux transporters Mrp3 and Mrp4. Induction of Mrp3 and Mrp4 by CFB may alter the disposition of toxicants and xenobiotics that are substrates for these transporters.
Footnotes
-
This research was supported by National Institutes of Health Grants ES10093 and ES09716 and the University of Connecticut Research Foundation.
-
doi:10.1124/jpet.105.093765.
-
ABBREVIATIONS: Ntcp, sodium-taurocholate cotransporting polypeptide; Oatp, organic anion transporter polypeptide; Bcrp, breast cancer resistance protein; Mdr, multidrug resistance protein; P-gp, P-glycoprotein; Mrp, multidrug resistance-associated protein; PPAR, peroxisome proliferator-activated receptor; PP, peroxisome proliferator; CFB, clofibrate; bDNA, branched DNA; RLU, relative light unit; PBS, phosphate-buffered saline; O.D., optical density.
-
↵ The online version of this article (available at http://jpet.aspetjournals.org) contains supplemental material.
- Received August 4, 2005.
- Accepted February 6, 2006.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|